Modern Hypolipidemic Therapy in Patients with Arterial Hypertension with High Cardiovascular Risk Under Conditions of Long-Term Ambulatory Observation
Ruziyeva Amira AsrorovnaAssistant, Department of Internal Medicine of the Pediatric Faculty with a Course of Therapy and Faculty after Graduation, Samarkand State Medical Institute, Samarkand, Uzbekistan;Muradova Railya RustamovnaAssistant, Department of Pharmacology and Clinical Pharmacology, Samarkand State Medical Institute, Samarkand, UzbekistanTuraev Khikmatulla NegmatovichAssistant, Department of Pharmacology and Clinical Pharmacology, Samarkand State Medical Institute, Samarkand, UzbekistanNuralieva Rano MatyakubovnaAssistant, Department of Pharmacology and Clinical Pharmacology, Samarkand State Medical Institute, Samarkand, Uzbekistan
ABI
Аннотация
Globally, more human beings die from cardiovascular sickness (CVD) than from another motive. An envisioned 17.5 million humans died from CVD in 2012. Eighty % of those deaths are because of coronary heart assaults and strokes; greater than three-quarters of all deaths occurred in low-and center-earnings countries. In 2012, 34% of all deaths from CVD befell earlier than the age of 70 years. CVD disproportionately impacts low-and middle-earnings nations; in many nations, the financial and social burden is maximum a few of the negative and socially deprived.
Ҳали таржима қилинмаган
Мавзулар
Идентификаторлар
Иқтибослар ва манбалар
0 та иқтибос5 та фойдаланилган манба
Кўрсаткичлар — AkademScholar · Тез орада